| | | Combination Therapy with Midostaurin Improves Survival of AML Patients with FLT3 Mutations |  | Advertisements: |
|  12/07/09 NEW ORLEANS--A targeted drug that is active against acute myeloid leukemia (AML) is particularly effective when teamed with chemotherapy in patients whose cancer cells harbor a key genetic mutation, researchers at Dana-Farber Cancer Institute and their colleagues will report at the American Society of Hematology's (ASH) annual meeting on Monday, Dec. 7 (Ernest N. Morial Convention Center, Room ... READ FULL SOURCE |
Back to: Bristol CT news
Other news07/14/11 Kimberly-Clark Health Care announced the results of clinical trial data presented in late June at the annual meeting of the American Society of Interventional Pain Physicians in Arlington, VA.
07/19/11 The Associated Press The Associated Press OKLAHOMA CITY Research by two physicians at the University of Oklahoma's Peggy and Charles Stephenson Oklahoma Cancer Center will be featured during an upcoming national meeting in Florida. Physicians Chance Matthiesen of Billings and Michael Confer of Stillwater will present research findings at the annual Scientific Meeting of the American Society for ...
07/19/11 ( American Society for Radiation Oncology ) The American Society for Radiation Oncology has named its 2011 class of Fellows. These 21 distinguished members will receive their Fellow designation at a ceremony during the Society's 53rd Annual Meeting being held Oct. 2-6, 2011, at the Miami Beach Convention Center in Miami Beach, Fla. Hot themes this week:
|
| |
| | HOT towns and cities: Waterbury, CT news • Stamford, CT news • West Haven, CT news • Europe, CT news • Bethel, CT news • New Fairfield, CT news • North Haven, CT news • Westbrook, CT news • North Stamford, CT news • Lyme, CT news • Madison, CT news • East Hartford, CT news • Rocky Hill, CT news | |
|
(c) ProvinceCity.com - news and events from small towns, cities and megapolises. All rights reserved. |
| |
Home Sitemap 0 news added |
|
|